Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
China Resources Pharmaceutical Group
AddedFeb 13, 2024
UpdatedJun 28, 2026
China Resources Pharmaceutical Group

China Resources Pharmaceutical Group

Series B

Rhode Island-based medical organization, China Resources Pharmaceutical Group, researches, develops, and distributes diverse medicines across China.

HQ
Barrington, RI, US
Founded
2007
Overview
Compare
Fundraising
Employees

China Resources Pharmaceutical Group researches, develops, manufactures, and distributes a wide range of Chinese, western, and other medicines and health foods. The company aims to improve healthcare quality and accessibility, serving customers throughout China.

The company has made significant strides in the pharmaceutical industry, contributing to advancements in medicine and healthcare. Its impact is evident in its extensive distribution network and commitment to innovation in medical research and development.

Similar Companies

China Resources logo

China Resources

China PharmaHub logo

China PharmaHub

Zuellig Pharma China logo

Zuellig Pharma China

zuelligpharma.com

China Yongxin Pharmaceuticals logo

China Yongxin Pharmaceuticals

yongxinchina.com

CSR Pharma Group logo

CSR Pharma Group

csrpharmsvcs.com

Betta Pharmaceuticals Co. logo

Betta Pharmaceuticals Co.

bettapharma.com

Luye Pharma Group logo

Luye Pharma Group

Huadong Medicine logo

Huadong Medicine

Harbin Gloria Pharmaceuticals Co. logo

Harbin Gloria Pharmaceuticals Co.

Jianmin Pharmaceutical Group Co logo

Jianmin Pharmaceutical Group Co

China Grand Pharmaceutical and Healthcare Holdings logo

China Grand Pharmaceutical and Healthcare Holdings

Haisco logo

Haisco

Yantai Dongcheng Pharmaceutical Co logo

Yantai Dongcheng Pharmaceutical Co

dcb-group.com

Sino Biopharmaceutical logo

Sino Biopharmaceutical

Jianke logo

Jianke

jianke.com

China Resources Pharmaceutical Group - Quick Facts

Who are China Resources Pharmaceutical Group's competitors?

Companies similar to China Resources Pharmaceutical Group include China Resources, China PharmaHub, Zuellig Pharma China and China Yongxin Pharmaceuticals.

When was China Resources Pharmaceutical Group founded?

China Resources Pharmaceutical Group was founded in 2007.

Where is China Resources Pharmaceutical Group's headquarters located?

China Resources Pharmaceutical Group's headquarters is located in Barrington, RI, US.

When was China Resources Pharmaceutical Group's last funding round?

China Resources Pharmaceutical Group's most recent funding round was for $600M (USD) in January 2023.

How much has China Resources Pharmaceutical Group raised to-date?

As of Jan 10, 2023, China Resources Pharmaceutical Group has raised a total of $600M (USD).

How many employees does China Resources Pharmaceutical Group have?

China Resources Pharmaceutical Group has 20 employees as of Feb 4, 2024.

China Resources Pharmaceutical Group - Classification

NAICS
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 5900Miscellaneous Retail
  • 2830Drugs
  • 5910Drug Stores And Proprietary Stores
  • 2834Pharmaceutical Preparations